Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) has issued an announcement.
Innovative Pharmaceutical Biotech Limited has announced its upcoming annual general meeting scheduled for August 29, 2025, in Hong Kong. The agenda includes the adoption of financial statements, re-election of directors, and re-appointment of auditors. Additionally, a resolution will be considered to authorize the directors to allot and issue shares, which could impact the company’s capital structure and shareholder value.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company incorporated in the Cayman Islands and continued in Bermuda with limited liability, operating within the pharmaceutical and biotechnology industry. The company is listed on the Hong Kong Stock Exchange under the stock code 399, focusing on developing innovative pharmaceutical products and biotechnological solutions.
Average Trading Volume: 17,762,668
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.3B
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.